Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Payables (2016 - 2025)

Historic Payables for Nutex Health (NUTX) over the last 17 years, with Q3 2025 value amounting to $45.5 million.

  • Nutex Health's Payables rose 34060.94% to $45.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.5 million, marking a year-over-year increase of 34060.94%. This contributed to the annual value of $9.6 million for FY2024, which is 4913.01% down from last year.
  • According to the latest figures from Q3 2025, Nutex Health's Payables is $45.5 million, which was up 34060.94% from $28.1 million recorded in Q2 2025.
  • Nutex Health's Payables' 5-year high stood at $45.5 million during Q3 2025, with a 5-year trough of $4.2 million in Q1 2022.
  • Moreover, its 5-year median value for Payables was $16.7 million (2024), whereas its average is $16.3 million.
  • In the last 5 years, Nutex Health's Payables surged by 114835.2% in 2021 and then tumbled by 4913.01% in 2024.
  • Quarter analysis of 5 years shows Nutex Health's Payables stood at $14.5 million in 2021, then soared by 63.31% to $23.6 million in 2022, then fell by 19.97% to $18.9 million in 2023, then tumbled by 49.13% to $9.6 million in 2024, then surged by 373.01% to $45.5 million in 2025.
  • Its Payables was $45.5 million in Q3 2025, compared to $28.1 million in Q2 2025 and $19.8 million in Q1 2025.